Familial hypercholesterolaemia trials in Poland

In Poland 6 Also abroad 115

6 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 11 November 2026. Ask the study team whether a trial fits you.

Phase 2/3Taking people
A Study of Enlicitide Decanoate (MK-0616, an Oral PCSK9 Inhibitor) in Children and Adolescents With Heterozygous Familial Hypercholesterolemia (MK-0616-029)
Where
Gdansk, Lodz
Age
6 years to 17 years
People
153 worldwide
Run by
Merck Sharp & Dohme LLC
See details and how to joinNCT07058077 · EU 2024-519068-42-00
Phase 3Taking people
Comparison of inclisiran or alirocumab to standard therapy in pediatric heterozygous familial hypercholesterolemia (HeFH) – the head-to-head PICOLO-FH clinical trial
Where
Gdansk, Lodz
Age
Up to 17 years
People
400
Run by
Medical University Of Lodz
See details and how to join2024-514523-42-00 · EU 2024-514523-42-00
Phase 3Taking people
Study of Zodasiran in Adolescent Participants With Homozygous Familial Hypercholesterolemia
Where
Warsaw
Age
12 years to 17 years
People
10 worldwide
Run by
Arrowhead Pharmaceuticals
See details and how to joinNCT07473843 · EU 2025-523662-24-00
Phase 3Taking people
Long-term Safety and Tolerability of Inclisiran in Participants With HeFH or HoFH Who Have Completed the Pediatric ORION-16, ORION-13, ORION-20, or ORION-19 Studies
Where
Gdansk, Lodz
Age
2 years to 100 years
People
195 worldwide
Run by
Novartis Pharmaceuticals
See details and how to joinNCT05682378
Phase 3Taking people
Study to Evaluate Efficacy and Safety of Inclisiran in Children With Heterozygous Familial Hypercholesterolemia
Where
Bialystok, Gdansk, Lodz
Age
6 years to 11 years
People
60 worldwide
Run by
Novartis Pharmaceuticals
See details and how to joinNCT06597019
No phaseTaking people
PMMHRI-Pitavastatin Registry
Where
Lodz
Age
18 years and over
People
500
Run by
Polish Mother Memorial Hospital Research Institute
See details and how to joinNCT06858982